SLT versus other treatment options

Article

SLT is a popular treatment option for glaucoma. In this article, Dr McAlinden discusses his recent paper that reviewed comparative studies from peer-reviewed journals, finding encouraging and reassuring results about SLT.

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Osamah Saeedi, MD, MS, at ARVO 2024
Dr Nir Shoham Hazon, Director, Miramichi EyeNB Centre of Excellence, New Brunswick, Canada
Paul Harasymowycz, MD
Ms Neeru Vallabh on a virtual call with Ophthalmology Times Europe
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Related Content
The AAO logo and Giovanni Montesano, MD, Moorfields Eye Hospital and City, University of London

Six-year findings from laser in glaucoma and ocular hypertension (LiGHT)

By Lynda Charters; reviewed by Giovanni Montesano, MD
October 20th 2024
Article

In visual field progression results, SLT was superior to ocular drops as first-line treatment for patients with glaucoma

Two elderly people look at a map. Image credit: ©Rawpixel.com – stock.adobe.com

Study examines navigation performance in glaucoma with virtual-reality-based assessment of path integration

David Hutton
September 16th 2024
Article

Uncertainty during everyday navigation tasks may adversely affect quality of life for patients with glaucoma

A cell being injected by a syringe. Image credit: ©Corona Borealis – stock.adobe.com

Trinity team’s gene therapy offers promising glaucoma and AMD treatment

Martin David Harp
September 9th 2024
Article

Research by investigators at Trinity College in Dublin, Ireland shows how the gene therapy conferred significant protection for retinal ganglion cells

An ophthalmologist conducts an exam on an elderly female patient. Image credit: ©Yakobchuk Olena – stock.adobe.com

Why the future of glaucoma care is in the operating room

Hattie Hayes; Reviewed by Norbert Pfeiffer, MD
August 14th 2024
Article

Smaller surgeries, in greater numbers, await new glaucoma specialists

A collection of purple lasers shoot from a central light source. Image credit: ©monsifdx – stock.adobe.com

ViaLase Laser receives CE Mark, announces first EU distribution partners

Hattie Hayes
July 30th 2024
Article

Femtosecond laser, image-guided, high-precision trabeculotomy (FLigHT) received approval for patients in Europe with primary open-angle glaucoma

Cells under a microscope. They are connected by red lines representing charted growth data. Image credit: ©Naphatson – stock.adobe.com

Insights into neovascular glaucoma: Pathogenesis and detection of diabetic retinopathy

Palla Deepika
July 1st 2024
Article

Management of neovascular glaucoma focuses on decreasing retinal ischemia through panretinal photocoagulation and the injection of anti-VEGF agents

© 2024 MJH Life Sciences

All rights reserved.